Stay updated on Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.

Latest updates to the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page
- Check5 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry (v3.7.0) was added to the study record history, replacing the previous revision (v3.6.6).SummaryDifference0.1%

- Check47 days agoChange DetectedThe record history adds a new revision entry v3.6.6, and the previous revision v3.6.5 is removed. This represents a minor metadata update to the study record.SummaryDifference0.1%

- Check68 days agoChange DetectedThe record history now shows a new revision entry (v3.6.5) replacing the previous revision (v3.6.4), indicating an updated revision of the page.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision entry v3.6.4 is added to the study record history, signaling a newer version of the record. The previous revision v3.6.3 is removed from the visible history to reflect the latest update.SummaryDifference0.1%

- Check105 days agoChange DetectedA new revision entry, v3.6.3, was added to the record history, replacing the previous v3.6.2. This reflects a latest update to the study record page.SummaryDifference0.1%

Stay in the know with updates to Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.